- Website
- Locations
- Baltimore
- Moscow
- Company size
- 11-50 people
- Total raised
- $96.5M
- Markets
People at Insilico Medicine
Eugeniya Cheskidova
student at MIPT, worked for a year year as data analyst at InSilicoMedicine inc.
Alexander H. Perkins
Eugene Makarev
Vice President at Insilico Medicine
Ph.D. in cell biology, postdoctoral training at NIH, specializing in model development for drug discovery and regen medicine
Evgeny Putin
Experience in Machine Learning, Deep Learning, Bioinformatics, Computer Vision, NLP
Ksenia Lezhnina
The Head of Pathway Analysis Group at InSilico Medicine, Inc
Marine Bozdaganyan
Alex Aliper
Alex Aliper is a president of Insilico Medicine, Inc. a Baltimore-based bioinformatics company focused on reinventing drug discovery and biomarker development.
Quentin Vanhaelen
Director, Simulations, Research scientist at Insilico Medicine
Jane Schastnaya
Artem V. Artemov
Director of drug discovery at Insilico Medicine
Teaching R and statistics at @Lomonosov Moscow State University, faculty of Bioengineering and Bioinformatics
Mikhail KORZINKIN
Employee
Ivan Ozerov
PhD in Radiation Biology, experience in bioinformatics, computer vision, medical imaging
Polina Mamoshina
A research scientist currently based in Oxford, UK
Qingsong Zhu
Chief operating officer at Insilico Medicine, Inc.
Ph.D. in biochemistry, trained and worked at Johns Hopkins University SOM, experienced in drug development